Summary: The total and Ultrafiltrable citrate of serum were measured in healthy controls, and in patients with calcium-containing kidney stones classified into the various calciuria types (normocalciuria, renal, absorptive, resorptive hypercalciuria). The total citrate in two subgroups (normocalciuria, renal hypercalciuria) was significantly higher than in controls. Two independent analyses showed a mean Ultrafiltrable fraction of 0.86 (controls and stone formers, with the exception of resorptive hypercalciuria) and 0.95 (resorptive hypercalciuria), i.e. the calculated extent of binding of citrate to serum macromolecules (> 10000 Daltons). The differences in the fraction of free citrate between controls and renal stone formers are not sigriificant. The apparent mean association constants are (1/mol) 0.24 X l O 2 (controls) and 0.29 X l O 2 (noimocalciuria). There is a high correlation between the ultrafiltrable fraction and total citrate in the serum, and also between the ratlos urinary/serum creatinine and urinary/ serum total citrate, during a 2 h endogenous creatinine clearance in the morning (fast in g). These findings suggest that 1) there is citrate binding in the serum, 2) the normal portion of free citrate in total serum citrate of normocalciuric stone formers cannot explain the decreased citrate excretion in 24 h urine of these subjects,
Introduction
Citrate is considered an important chelator of cations such äs calcium and magnesium in biological Systems like bone and urine. In the latter milieu it reduces the concentration of free calcium ions available for nucleation with phosphate and oxalate (l, 2). Therefore, the inhibitory activity of citrate with respect to stoneforming processes led investigators to search for abnonnalities of citrate metabolism in renal stone disease.
In a previous (3) and an accompanying (4) study we have been able to demonstrate that, in the absence of primary hyperparathyroidism, urinary citrate excretion during a 2 h morning clearance period is not different fröm controls in patients with recurrent idiopathic calcium and uric acid stone formation, although at the same time serum citrate is elevated in stone formers äs a whole. This observation prompted the present investigätion into possible differences in the citrate fraction freely filtrable at the glomerular level in subgroups of calcium lithiasis, since such a phenomenon might be at least a partial explanation for differences in urinary citrate excretiori.
Subjects and Methods
A total of 36 healthy controls (d/9 = 20/16) from the hospitäl staff (22-69 years; median 40) and 74 non-acidotic patients (d/9 = 44/30) with metabolically active recurrent renal calcium stone formation (20-71 years; median 46) were studied whüe on their usual home diet. The renal function was normal (serum creatinine < 13 mg/1; endogenous creatinine clearance > 60 ml/ min) in all subjects, and no other serious ülnesses were detectable at the time of examination. Following a 12^15 h overnight fasting period at home, antebrachial venous blood was drawn anaerobically into 5 ml-vacutainers without additive (Becton-Dickinson; Hamburg) at 8 a.m. in the laboratöry with subjects seated. Gare was taken not to apply stasis to the blood vessel after hiaving punctured it. Then diuresis was stimuläted by the administration of 2 X 300 ml tap water, and a 2 h clearance period started after bladder voiding. The urinary calcium/creatinine ratio iii this period and its response to a test meal in a subsequent 3 h collection period permitted classification of the patients into the various calciurias (normocalciuria, absorptive, renal leak, bone resorptive 1 ) hypercalciuria) (5, 6) . The study of serum citrate fractions was restricted to a limited number of controls (n = 13; <5/9 = 9/4), normocalciuria (n = 13; d/9 = 10/3), absorptive (n = 2; c5/9 -0/2), renal (n = 7; d/9 = 3/4), resorptive (n = 5; <J/9 = 2/3) hypercalciuria. Technique for determination of ultrafiltrable citrate: to 2 ml of fresh anaerobically handled serum (second 3 ml vacutainer) [l, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]citrate (Radiochemical Centre Amersham; England), appr. 1111-1295 Bq (30-35 nCi), was added and the mixture allowed to stand for at least 15 min at room temperature. Thereafter it was transferred to a pre-washed (0.15 mol/1 Nad) yisking tube (< 10000 Daltons; Serva, Heidelberg), which was immediately knotted and inserted into a specially manufactured glass centrifuge tube (7) which was then tightly stoppered. This tube was spun for 3 h at 3 000 min' 1 and 37 °C in a prewarmed JA-21 B (Beckman, Palo Alto) refrigerating centrifuge. The System keeps sample pH below 7.50. Citrate (cold; radioactiye) and total protein were measured in both the ultrafüträte and the supernatant. In addition urinary citrate (2 h morning, 24 h urine), creatinine (2 h urine oniy), and serum citrate, creatinine, inorganic phosphate and free fatty acids, were determined in groups of controls and normocalciuric stone patients (for number of observations see results).
Analyses and calculations
Creatinine was measured by a Technicon-Autoanalyzer, phosphate by a micrpmethod (8), free fatty acidS by micro-titrimetry (9), total protein by refractornetry, J
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CJcitrate radioactivity in a BF-5000 (Berthold; Wüdbad) liquid scintillation spectrophotometer using 10 ml Unisolve Cocktail (Zinsser; Frankfurt) per sample (50 ). The citrate lyase method äs origjnally described (10) was used for citrate determination in perchlöric acid (0.6 mol/1) extracts of serum (l ml serum + 2 ml perchlöric acid), whüe in order to achieve quantitative citrate measurement in urine (pH 5.0-7.8) the sample was pre-titrated (0.1 iriöl/1 NäOH) to pH 8.5 (citratelyase pH pptimum: 8.2-8.6). Precision (CV%) was 2.74 (serum) and 1.23 (urine) in repeat determinatipns (n = 8-10) of a given sample (= intraassay CV). Recovery (%) of citrate added to serum was 97 ± 7.1 (SD), 99.3 ± 3.9 (dilution f^ctors in serum extracts), 99.9 ±1.7 (citrate added to urine), 1ÖÖ.1 ± 0.6 (dilution factors in urine), consistent with an overall (0.4-25 nmolA) complete citrate recovery of 100.0 ±1.2%. Compaiability of citrate concentration in ultrafiltrate and serum necessitates corrections for the unit pläsma water (11) allowing for protein volume (serum) pr content of solutes (ultrafiltrate, Donnan factor .05). All results are expressed äs means with l Standard error of the mean. Significance of differences was set at the 5 per cent probability level (Studenfs tatest).
Results and Corriments
Totaland ultrafiltrable citrate of serum (tab. 1) Total citrate in eontrols was in'the ränge reported by others (12) and ourselves (4), using the same method, and the higher mean valties in renal stone disease (4) were confirmed. For the first time, to our knowledge, the table provides data on ultrafiltrable citrate obtained with two different analytical methods (enzymatic; radioactivity-related).
The validity of the ultrajSltratipn prpcedüre häs been demonstrated: according to the conceptual model of Ultrafiltration oütliried by Terepka et aL (l 1) the protein concentration remaining in the supernatant after centrifugation increases, while the concentration of the ligand under study decreases (so-called.Sandwich subtraction).
For both citrate and [* 4 C]citratej Üiese two important criteria are fulfilled. If we consider the technique used to be acceptable, there still remains a fraction of serum citrate that escapes Ultrafiltration, and which might be bound to serum macrpmolecules (> 10000 Daltons). The fraction of ultrafiltrable citrate varies between 0.86 (controls, normocalciuria, absorptive, renal hypercalciuria) and 0.95 (resorptive hypercalciuria), while with [ (7)) or greater (free fatty acids; see below).
However, the present work shows that the fraction of free citrate, and hence that of bound citrate in stone disease does not differ significantly from that of controls.
This seems remarkable in view of the serum concentration of the above constituents in normocalciuria (accounting for approx. 60 percent of all calcium stone formers), which is lower (phosphate; tab. 2) or higher (free fatty acids; tab. 2) than normal, while urate is unchanged (not shown). Assuming a normal serum albumin concentration (45 g/l) and a single class of binding sites in controls and normocalciuria we calculated, in accordänce with Goldstein 2 (13), the following approximate apparent association eonstants (1/mol), äs based on the mean fraction citrate bound, which had been extrapolated from the mean ultrafiltrable fraction: controls K = 0.24 X 10 Although these values would fall within the ränge of urate binding (K = 0.6 10 2 (7,14)) they are higher than for phosphate (K = 1.5 X IQ 1 approx. (15)), and much lower than for free fatty acids (K = l. l X l O 7 approx. (16)). Thus normal fractions of free and bound citrate in normocalciuric stone formers is an unexpected finding. One can only speculate äs to whether differences in affinity of individual free fatty acids to binding sites or, alternatively, the available number of binding sites, account for this finding.
The relationship between serum and urinary citrate
The manner in which citrate arriving in the glomemlar ultrafiltrate is handled by the human kidney is largely 2 ) using the formula: fraction bound (inol/1) = n X K X [PJ, where n is the number of binding sites, [P] serum albumin ( / = 65 000) concentration, K association constant. unknown. If citrate excreted in urine were determined mainly by the filtered load of citrate in the early proximal tubule a rather close coupling of urinary citrate excretion and the filtered load (= prpduct of endogenous creatinine clearance and free serum citrate) of citrate would be expected, äs in the case of substances which either are bnly filtered (e.g. endogenous creatinine) or are not reabsorbed in substantial amounts beyond the proximal tubule (e.g. phosphate). In the case of unaltered endogenous creatinine clearance in calcium stone formers, a fact well documented, the filtered load of citrate to the proximal tubule would be dependent mainly on free citrate in the serum. We found that the latter and total serum citrate are highly correlated in controls and normocalciuric stone forming individuals (r = 0.974 and r = 0.932 respectively) who participated in our ultrafiltration study (tab. 1). These facts lead us to hypothesize that free and bound serum citrate can be predicted from the ratio of the concentrations of creatinine in the urine and serum, and from urinary citrate, provided that there is a sufficiently high correlation between this ratio of both substances. This is recognisably the case in the two groups (controls; normocalciuria) shown in figure l. It seems therefore, that under the present conditions of examination in the laboratory (morning endogenous creatinine clearance following an overnight fast) urinary citrate is in fact governed by the glomerular filtration rate and serum citrate. The significance of this for practical work is that routine measurements of urinary creatinine and citrate, together with serum creatinine, yield relatively accufate Information on the state of serum citrate.
From the above, the unchanged fraction of ultrafdtrable serum citrate (tab. 1) and the normal urinary citrate excretion in all groups during a 2 h fasting period (tab. 2), it is clear however, that there is a net tubular reabsorption of citrate during health (renal citrate clearance is approx. 10-15 ml/min), but considerably enhanced citrate reabsorption in calcium stone disease. If statte serum citrate is assumed, citrate reabsorption in calcium stone disease may be further exaggerated during a 24 h daily cycle and thereby help to create the now recqgnized deficiency in urinary Qitrate of normocalciuric stone-forming individuals (tab. 2; I.e. 3,4)). In conclusion, these considerätions riiäy help to further the understanding of citrate metabolism and to focus citrate research in calcium stone disease on the kidney. 
